NeuroPace, Inc.
NPCE
$10.79
$0.363.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 21.47M | 21.06M | 19.26M | 18.12M | 18.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.47M | 21.06M | 19.26M | 18.12M | 18.01M |
| Cost of Revenue | 5.28M | 5.64M | 5.12M | 4.78M | 4.47M |
| Gross Profit | 16.19M | 15.42M | 14.13M | 13.34M | 13.55M |
| SG&A Expenses | 13.79M | 13.91M | 14.30M | 15.10M | 13.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.12M | 25.30M | 25.49M | 25.67M | 23.06M |
| Operating Income | -3.65M | -4.24M | -6.23M | -7.55M | -5.05M |
| Income Before Tax | -5.25M | -5.45M | -7.51M | -8.93M | -6.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.25M | -5.45M | -7.51M | -8.93M | -6.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.25M | -5.45M | -7.51M | -8.93M | -6.20M |
| EBIT | -3.65M | -4.24M | -6.23M | -7.55M | -5.05M |
| EBITDA | -3.61M | -4.19M | -6.17M | -7.50M | -5.01M |
| EPS Basic | -0.18 | -0.19 | -0.26 | -0.32 | -0.23 |
| Normalized Basic EPS | -0.11 | -0.12 | -0.16 | -0.20 | -0.14 |
| EPS Diluted | -0.18 | -0.19 | -0.26 | -0.32 | -0.23 |
| Normalized Diluted EPS | -0.11 | -0.12 | -0.16 | -0.20 | -0.14 |
| Average Basic Shares Outstanding | 29.91M | 29.44M | 28.85M | 28.29M | 26.80M |
| Average Diluted Shares Outstanding | 29.91M | 29.44M | 28.85M | 28.29M | 26.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |